ShreeOswal Seeds and Chemicals (OSWALSEEDS)₹11.53−0.77%Other Agricultural Products
In the Jun 2026 quarter (consolidated), ShreeOswal Seeds and Chemicals reported sales of ₹117 Cr, up 19.4% from Jun 2025, and net profit of ₹11.98 Cr, up 71.4% year on year. For the year to Mar 2026, sales were ₹247 Cr and net profit ₹6.99 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 65.83 | 76.76 | 42.85 | 76.74 | 67.84 | 74.82 | 25.93 | 97.69 | 38.89 | 54.81 | 55.86 | 117 |
| Expenses | 62.74 | 77.71 | 47.82 | 78.75 | 65.75 | 66.71 | 23.91 | 86.70 | 42.86 | 51.84 | 51.83 | 98.56 |
| Operating Profit | 2.01 | −1.01 | −5.01 | −2.01 | 2.01 | 8.02 | 2.01 | 11.02 | −4.01 | 3.01 | 4.01 | 18.04 |
| OPM % | 3.7% | −1.5% | −11.0% | −2.6% | 2.3% | 11.0% | 8.0% | 11.0% | −9.0% | 5.0% | 7.0% | 16.0% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.99 | 1.99 | 1.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.99 | −2.99 | −5.99 | −3.99 | 0.00 | 6.99 | 0.99 | 9.99 | −4.99 | 0.99 | 2.99 | 16.99 |
| Tax % | 28.0% | 15.0% | −43.0% | −24.0% | 31.0% | 26.1% | 40.0% | 28.0% | −31.0% | 28.0% | 22.0% | 27.0% |
| Net Profit | 0.99 | −2.99 | −3.99 | −2.99 | 0.00 | 4.99 | 0.99 | 6.99 | −2.99 | 0.99 | 1.99 | 11.98 |
| EPS (Rs) | 0.06 | −0.35 | −0.37 | −0.31 | 0.02 | 0.58 | 0.07 | 0.79 | −0.34 | 0.10 | 0.22 | 1.33 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17.95 | 126 | 117 | 160 | 240 | 271 | 268 | 245 | 247 | 266 |
| Expenses | 15.95 | 120 | 110 | 153 | 229 | 259 | 267 | 235 | 233 | 245 |
| Operating Profit | 2.01 | 6.02 | 7.01 | 8.02 | 10.02 | 12.03 | 1.01 | 10.03 | 15.03 | 21.05 |
| OPM % | 10.0% | 5.0% | 6.0% | 4.8% | 4.3% | 4.4% | 0.4% | 3.9% | 6.0% | 7.9% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.99 | 1.99 | 1.99 | 1.99 | 2.99 | 3.99 | 5.98 | 3.99 | 4.98 | 3.96 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 1.01 | 0.00 |
| Profit before tax | 0.99 | 3.99 | 3.99 | 4.99 | 7.99 | 7.99 | −4.99 | 4.99 | 9.99 | 15.98 |
| Tax % | 20.1% | 26.0% | 28.0% | 28.0% | 28.0% | 28.0% | −23.0% | 31.0% | 25.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.99 | 2.99 | 2.99 | 3.99 | 4.99 | 5.99 | −3.99 | 3.99 | 6.99 | 11.97 |
| EPS (Rs) | 0.19 | 0.30 | 0.32 | 0.39 | 0.58 | 0.61 | −0.44 | 0.40 | 0.78 | 1.31 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11.02 | 15.02 | 15.02 | 15.03 | 15.02 | 15.03 | 18.02 | 18.02 | 18.02 |
| Reserves | 1.01 | 11.04 | 14.05 | 18.07 | 23.05 | 29.07 | 22.07 | 25.08 | 33.13 |
| Borrowings | 24.96 | 23.97 | 29.97 | 43.00 | 41.92 | 40.97 | 63.91 | 41.91 | 5.99 |
| Other Liabilities | 15.07 | 11.06 | 7.02 | 16.07 | 40.11 | 43.17 | 20.10 | 19.03 | 83.92 |
| Total Liabilities | 52.06 | 61.09 | 66.06 | 93.17 | 120 | 128 | 124 | 105 | 141 |
| Fixed Assets | 1.99 | 1.99 | 3.99 | 3.99 | 3.99 | 3.99 | 6.98 | 5.99 | 7.98 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 1.99 | 1.99 | 0.99 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 50.07 | 59.10 | 63.07 | 89.18 | 115 | 122 | 115 | 96.06 | 131 |
| Inventories | 32.91 | 41.89 | 40.90 | 74.83 | 88.73 | 103 | 82.81 | 64.81 | 81.80 |
| Trade receivables | 10.96 | 10.97 | 11.97 | 5.98 | 18.94 | 7.98 | 16.95 | 12.95 | 34.87 |
| Cash & equivalents | 0.99 | 3.99 | 1.99 | 0.99 | 1.99 | 4.98 | 2.99 | 0.00 | 0.99 |
| Total Assets | 52.06 | 61.09 | 66.06 | 93.17 | 120 | 128 | 124 | 105 | 141 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −10.02 | −10.02 | −4.01 | −11.01 | 5.01 | 12.02 | −15.03 | 24.04 | −14.01 |
| Cash from investing activity | 0.00 | 0.99 | −2.99 | 0.00 | −0.99 | −1.99 | −3.99 | −0.99 | −0.99 |
| Cash from financing activity | 9.97 | 12.97 | 3.99 | 9.97 | −3.99 | −5.98 | 16.96 | −25.90 | 14.95 |
| Net cash flow | 0.00 | 2.99 | −2.99 | −0.99 | 0.99 | 2.99 | −1.99 | −2.99 | 0.99 |
| Capex | 0.02 | 0.06 | 1.92 | 0.73 | 0.87 | 0.39 | 2.84 | 0.21 | 0.76 |
| Free cash flow | −9.99 | −9.98 | −5.99 | −11.99 | 3.99 | 10.99 | −18.97 | 23.96 | −13.98 |
| CFO / OP % | −525.0% | −149.0% | −38.0% | −123.0% | 72.0% | 119.0% | −1,388.0% | 253.0% | −87.0% |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 226 | 31 | 38 | 13 | 28 | 10 | 23 | 18 | 50 |
| Inventory days | 789 | 133 | 146 | 189 | 143 | 146 | 1,539 | 473 | 133 |
| Days payable | 335 | 29 | 4 | 5 | 6 | 5 | 54 | 31 | 101 |
| Cash conversion cycle | 683 | 137 | 182 | 201 | 168 | 154 | 1,511 | 462 | 85 |
| Working capital days | 212 | 60 | 75 | 76 | 57 | 48 | 37 | 50 | 62 |
| ROCE % | — | 13.9% | 11.9% | 10.9% | 13.0% | 13.9% | 1.0% | 10.0% | 19.9% |
For the Jun 2026 quarter, ShreeOswal Seeds and Chemicals reported sales of ₹117 Cr, up 19.4% year on year and net profit of ₹11.98 Cr, up 71.4% year on year. The operating margin was 16.0%.
ShreeOswal Seeds and Chemicals' sales for the year to Mar 2026 were ₹247 Cr; over the last twelve months they were ₹266 Cr.
Net profit for the year to Mar 2026 was ₹6.99 Cr, and ₹11.97 Cr over the last twelve months. Earnings per share over the same trailing period were ₹1.31.
ShreeOswal Seeds and Chemicals reported borrowings of ₹5.99 Cr at Mar 2026, against cash and equivalents of ₹0.99 Cr.
Cash from operations was −₹14.01 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹13.98 Cr.